168 related articles for article (PubMed ID: 27725228)
1. EGFL7 is an intercellular EGFR signal messenger that plays an oncogenic role in glioma.
Wang FY; Kang CS; Wang-Gou SY; Huang CH; Feng CY; Li XJ
Cancer Lett; 2017 Jan; 384():9-18. PubMed ID: 27725228
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of EGFL7 in malignant glioma.
Huang CH; Li XJ; Zhou YZ; Luo Y; Li C; Yuan XR
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1737-43. PubMed ID: 20213100
[TBL] [Abstract][Full Text] [Related]
3. EGFR/EGFRvIII remodels the cytoskeleton via epigenetic silencing of AJAP1 in glioma cells.
Yang C; Li YS; Wang QX; Huang K; Wei JW; Wang YF; Zhou JH; Yi KK; Zhang KL; Zhou BC; Liu C; Zeng L; Kang CS
Cancer Lett; 2017 Sep; 403():119-127. PubMed ID: 28634045
[TBL] [Abstract][Full Text] [Related]
4. VE-statin/Egfl7 expression in malignant glioma and its relevant molecular network.
Huang C; Yuan X; Wan Y; Liu F; Chen X; Zhan X; Li X
Int J Clin Exp Pathol; 2014; 7(3):1022-31. PubMed ID: 24696719
[TBL] [Abstract][Full Text] [Related]
5. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
6. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of LN-308 glioma cell proliferation and migration by retinoic acid amide through activation of Akt pathway.
Zhu J; Lu XD; Si F; Song CY; Meng QH
Int J Clin Exp Pathol; 2015; 8(11):13921-7. PubMed ID: 26823704
[TBL] [Abstract][Full Text] [Related]
8. VE-statin/Egfl7 siRNA inhibits angiogenesis in malignant glioma in vitro.
Huang C; Yuan X; Li Z; Tian Z; Zhan X; Zhang J; Li X
Int J Clin Exp Pathol; 2014; 7(3):1077-84. PubMed ID: 24696724
[TBL] [Abstract][Full Text] [Related]
9. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
10. MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling.
Chen L; Zhang A; Li Y; Zhang K; Han L; Du W; Yan W; Li R; Wang Y; Wang K; Pu P; Jiang T; Jiang C; Kang C
Cancer Lett; 2013 Feb; 329(2):174-80. PubMed ID: 23142218
[TBL] [Abstract][Full Text] [Related]
11. WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.
Denysenko T; Annovazzi L; Cassoni P; Melcarne A; Mellai M; Schiffer D
Cancer Genomics Proteomics; 2016; 13(1):31-45. PubMed ID: 26708597
[TBL] [Abstract][Full Text] [Related]
12. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.
Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L
Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor variant III renders glioma cancer cells less differentiated by JAGGED1.
Kim EJ; Kim SO; Jin X; Ham SW; Kim J; Park JB; Lee JY; Kim SC; Kim H
Tumour Biol; 2015 Apr; 36(4):2921-8. PubMed ID: 25514871
[TBL] [Abstract][Full Text] [Related]
15. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
[TBL] [Abstract][Full Text] [Related]
16. EGFL7 enhances surface expression of integrin α
Dudvarski Stanković N; Bicker F; Keller S; Jones DT; Harter PN; Kienzle A; Gillmann C; Arnold P; Golebiewska A; Keunen O; Giese A; von Deimling A; Bäuerle T; Niclou SP; Mittelbronn M; Ye W; Pfister SM; Schmidt MHH
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30065025
[TBL] [Abstract][Full Text] [Related]
17. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
Guo G; Narayan RN; Horton L; Patel TR; Habib AA
Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
[TBL] [Abstract][Full Text] [Related]
18. Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.
Wang L; Ye X; Cai X; Su J; Ma R; Yin X; Zhou X; Li H; Wang Z
Oncotarget; 2015 Jul; 6(20):18027-37. PubMed ID: 26046466
[TBL] [Abstract][Full Text] [Related]
19. F25P preproinsulin abrogates the secretion of pro-growth factors from EGFRvIII cells and suppresses tumor growth in an EGFRvIII/wt heterogenic model.
Wei JW; Cui JQ; Zhou X; Fang C; Tan YL; Chen LY; Yang C; Liu M; Kang CS
Cancer Lett; 2016 Sep; 380(1):1-9. PubMed ID: 27317648
[TBL] [Abstract][Full Text] [Related]
20. Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma.
Kessler T; Sahm F; Blaes J; Osswald M; Rübmann P; Milford D; Urban S; Jestaedt L; Heiland S; Bendszus M; Hertenstein A; Pfenning PN; Ruiz de Almodóvar C; Wick A; Winkler F; von Deimling A; Platten M; Wick W; Weiler M
Oncotarget; 2015 Oct; 6(31):31050-68. PubMed ID: 25682871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
